A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection

被引:22
|
作者
Zhu, M. -Y. [1 ]
Zou, X. [2 ]
Li, Q. [3 ]
Yu, D. -M. [1 ]
Yang, Z. -T. [4 ]
Huang, D. [1 ]
Chen, J. [1 ]
Gong, Q. -M. [1 ]
Zhang, D. -H. [1 ]
Zhang, Y. [2 ,5 ]
Chen, L. [3 ]
Chen, P. -Z. [6 ]
Zhang, X. -X. [1 ,6 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Infect Dis, Ruijin Hosp, Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Syst Biomed, Shanghai Ctr Syst Biomed, Shanghai, Peoples R China
[3] Fudan Univ, Dept Hepatitis, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Sch Med, Pole Sinofrancais Recherches Sci Vivant & Genom, Ruijin Hosp, Shanghai, Peoples R China
[5] Collaborat Innovat Ctr Syst Biomed, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Translat Med Res Ctr, Ruijin Hosp North, Sch Med, Shanghai, Peoples R China
基金
对外科技合作项目(国际科技项目);
关键词
blood biomarkers; chronic hepatitis B virus infection; diagnosis; liver fibrosis; GAMMA-GLUTAMYL-TRANSPEPTIDASE; HBV DNA; POSITIVE PATIENTS; PLATELET RATIO; VIRAL LOAD; DIAGNOSTIC-ACCURACY; CIRRHOSIS; BIOPSY; HBEAG; PREDICT;
D O I
10.1111/jvh.12682
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Several noninvasive blood biomarkers have been established for the assessment of liver fibrosis in patients with chronic hepatitis B virus (HBV) infection, but their clinical performance remains inconclusive. Here, we compared the diagnostic performance of these biomarkers and developed a novel algorithm for assessing liver fibrosis. Six hundred and sixteen chronically HBV-infected and treatment-naive patients who underwent liver biopsy were enrolled and randomly divided into training (N=410) and internal validation cohorts (N=206). One hundred and fifty-nine patients from another centre were recruited as an external validation cohort. Receiver operating characteristic (ROC) curves were used to analyse the performance of the gamma-glutamyltransferase-to-platelet ratio (GPR), red cell volume distribution width-to-platelet ratio (RPR), FIB-4 index, aspartate aminotransferase-to-platelet ratio index (APRI) and HBV DNA level against liver histology, and a novel algorithm was developed using the recursive partitioning and regression tree (RPART) method. In the training cohort, the area under the ROC curve of FIB-4 was significantly higher than that of APRI (P=.038) but was comparable to those of GPR, RPR and HBV DNA; however, the performance of the biomarkers was similar among the validation cohort. The established RPR-HBV DNA algorithm performed better in the training cohort than any individual blood biomarker, and the corresponding sensitivity, specificity, positive predictive value and negative predictive value were 63%, 90%, 72% and 80%, respectively. In the internal and external validation cohorts, the performance of the algorithm in assessing liver fibrosis was also superior to that of other biomarkers. These results suggest that the established RPR-HBV DNA algorithm might improve the diagnostic accuracy of liver fibrosis in treatment-naive patients with chronic HBV infection, although additional studies are warranted to confirm these findings.
引用
收藏
页码:589 / 598
页数:10
相关论文
共 50 条
  • [1] Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection
    Da-Wu Zeng
    Jing Dong
    Yu-Rui Liu
    Jia-Ji Jiang
    Yue-Yong Zhu
    [J]. World Journal of Gastroenterology, 2016, (29) : 6663 - 6672
  • [2] Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection
    Zeng, Da-Wu
    Dong, Jing
    Liu, Yu-Rui
    Jiang, Jia-Ji
    Zhu, Yue-Yong
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6663 - 6672
  • [3] Evaluation of eLIFT for Noninvasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection
    Li, Qiang
    Lu, Chuan
    Li, Weixia
    Huang, Yuxian
    Chen, Liang
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [4] A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection
    Cheng, Danying
    Wan, Gang
    Sun, Lei
    Wang, Xiaomei
    Ou, Weini
    Xing, Huichun
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [5] Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B
    Masaru Enomoto
    Hiroyasu Morikawa
    Akihiro Tamori
    Norifumi Kawada
    [J]. World Journal of Gastroenterology, 2014, (34) : 12031 - 12038
  • [6] Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B
    Enomoto, Masaru
    Morikawa, Hiroyasu
    Tamori, Akihiro
    Kawada, Norifumi
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (34) : 12031 - 12038
  • [7] Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection
    Ma, Jing
    Jiang, Yongfang
    Gong, Guozhong
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (04) : 428 - 434
  • [8] Noninvasive assessment of liver steatosis, fibrosis and inflammation in chronic hepatitis C virus infection
    Schneider, ARJ
    Teuber, G
    Kriener, S
    Caspary, WF
    [J]. LIVER INTERNATIONAL, 2005, 25 (06) : 1150 - 1155
  • [9] A noninvasive model for assessment of liver fibrosis of liver fibrosis in chronic hepatitis B
    Zhang, Wensheng
    Wang, Baoen
    Jia, Jidong
    Ou, Xiaojuan
    Wang, Tailing
    Chen, Yu
    Li, Qing
    Ma, Hong
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A81 - A81
  • [10] Noninvasive assessment of liver fibrosis in chronic hepatitis C infection
    Srygley F.D.
    Patel K.
    [J]. Current Hepatitis Reports, 2008, 7 (4) : 164 - 172